Clinical Trials List
2025-11-14 - 2031-03-30
Not yet recruiting6
ICD-10I50.20
Unspecified systolic (congestive) heart failure
ICD-10I50.21
Acute systolic (congestive) heart failure
ICD-10I50.22
Chronic systolic (congestive) heart failure
ICD-10I50.23
Acute on chronic systolic (congestive) heart failure
ICD-10I50.30
Unspecified diastolic (congestive) heart failure
ICD-10I50.31
Acute diastolic (congestive) heart failure
ICD-10I50.32
Chronic diastolic (congestive) heart failure
ICD-10I50.33
Acute on chronic diastolic (congestive) heart failure
ICD-10I50.40
Unspecified combined systolic (congestive) and diastolic (congestive) heart failure
ICD-10I50.41
Acute combined systolic (congestive) and diastolic (congestive) heart failure
ICD-10I50.42
Chronic combined systolic (congestive) and diastolic (congestive) heart failure
ICD-10I50.43
Acute on chronic combined systolic (congestive) and diastolic (congestive) heart failure
ICD-10I50.9
Heart failure, unspecified
ICD-9428.0
Congestive heart failure
-
-
Trial Applicant
IQVIA RDS Taiwan Ltd.
-
Sponsor
-
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/05/13
Investigators and Locations
Co-Principal Investigator
- 張獻元 Division of Cardiovascular Diseases
- 葉建寬 Division of Cardiovascular Diseases
- Po-Sheng Chen Division of Cardiovascular Diseases
- 李文煌 Division of Cardiovascular Diseases
- Po Wei Chen Division of Cardiovascular Diseases
- 陳則瑋 Division of Cardiovascular Diseases
The Actual Total Number of Participants Enrolled
0 Not yet recruiting
Co-Principal Investigator
- Yung-Ta Kao Division of Cardiovascular Diseases
- 鄭宇倫 Division of Cardiovascular Diseases
- 洪元 Division of Cardiovascular Diseases
- 陳彥舟 Division of Cardiovascular Diseases
- Chien-Yi Hsu Division of Cardiovascular Diseases
- 陳志維 Division of Cardiovascular Diseases
- 蕭卜源 Division of Cardiovascular Diseases
The Actual Total Number of Participants Enrolled
0 Not yet recruiting
Co-Principal Investigator
- Wen-Chung Yu Division of Cardiovascular Diseases
- Tse-Min Lu Division of Cardiovascular Diseases
- Kang-Ling Wang Division of Cardiovascular Diseases
- Chern-En Chiang Division of Cardiovascular Diseases
- 張皓智 Division of Cardiovascular Diseases
- 吳承學 Division of Cardiovascular Diseases
The Actual Total Number of Participants Enrolled
0 Not yet recruiting
Co-Principal Investigator
- Shih-Sheng Chang Division of Cardiovascular Diseases
- 林晏年 Division of Cardiovascular Diseases
- Lien-Cheng Hsiao Division of Cardiovascular Diseases
- 鍾偉信 Division of Cardiovascular Diseases
- 王宇澄 Division of Cardiovascular Diseases
- 陳恬恩 Division of Cardiovascular Diseases
The Actual Total Number of Participants Enrolled
0 Not yet recruiting
Co-Principal Investigator
- 朱志生 Division of Cardiovascular Diseases
- 吳韋璁 Division of Cardiovascular Diseases
- Po-Chao Hsu Division of Cardiovascular Diseases
- 林子傑 Division of Cardiovascular Diseases
- 黃天祈 Division of Cardiovascular Diseases
- Chun-Yuan Chu Division of Cardiovascular Diseases
- 徐旭亮 Division of Ophthalmology
The Actual Total Number of Participants Enrolled
0 Not yet recruiting
Co-Principal Investigator
- 李弘元 Division of Endocrinology
- MAO-HSIN LIN Division of General Internal Medicine
- 賀立婷 Division of General Internal Medicine
- 蘇乾嘉 Division of Ophthalmology
- Yi-Chih Wang Division of General Internal Medicine
- YEN-HUNG LIN Division of General Internal Medicine
- 洪啟盛 Division of General Internal Medicine
- 黃慶昌 Division of General Internal Medicine
- 江君揚 Division of General Internal Medicine
- 林柏志 Division of General Internal Medicine
- 陳盈憲 Division of General Internal Medicine
- Chih-Fan Yeh Division of General Internal Medicine
- Tzung-Dau Wang Division of General Internal Medicine
- JEN-KUANG LEE Division of General Internal Medicine
- 柯宗佑 Division of General Internal Medicine
- Kuo-Chin Huang Division of Family Medicine
The Actual Total Number of Participants Enrolled
0 Not yet recruiting
Study Contacts
- -
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
Exclusion Criteria
The Estimated Number of Participants
-
Taiwan
50 participants
-
Global
5056 participants
